168 related articles for article (PubMed ID: 8842040)
1. Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells.
Beck GF; Irwin WJ; Nicklin PL; Akhtar S
Pharm Res; 1996 Jul; 13(7):1028-37. PubMed ID: 8842040
[TBL] [Abstract][Full Text] [Related]
2. The influence of polarized epithelial (Caco-2) cell differentiation on the cellular binding of phosphodiester and phosphorothioate oligonucleotides.
Akhtar S; Beck GF; Hawley P; Irwin WJ; Gibson I
Antisense Nucleic Acid Drug Dev; 1996; 6(3):197-206. PubMed ID: 8915504
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.
Nakai D; Seita T; Terasaki T; Iwasa S; Shoji Y; Mizushima Y; Sugiyama Y
J Pharmacol Exp Ther; 1996 Sep; 278(3):1362-72. PubMed ID: 8819524
[TBL] [Abstract][Full Text] [Related]
4. Use of a simple fractionation method to evaluate binding, internalization and intracellular distribution of oligonucleotides in vascular smooth muscle cells.
Eboue D; Auger R; Angiari C; Le Doan T; Tenu JP
Arch Physiol Biochem; 2003 Jul; 111(3):265-72. PubMed ID: 14972750
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake properties of oligonucleotides in LLC-PK1 renal epithelial cells.
Takakura Y; Oka Y; Hashida M
Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):67-73. PubMed ID: 9512098
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylated phosphodiester gapmer designs with albumin binding capacity and maintained in vitro gene silencing activity.
Cai Y; Makarova AM; Wengel J; Howard KA
J Gene Med; 2018 Jul; 20(7-8):e3025. PubMed ID: 29800498
[TBL] [Abstract][Full Text] [Related]
7. The transport of acidic amino acids and their analogues across monolayers of human intestinal absorptive (Caco-2) cells in vitro.
Nicklin PL; Irwin WJ; Hassan IF; Mackay M; Dixon HB
Biochim Biophys Acta; 1995 Nov; 1269(2):176-86. PubMed ID: 7488651
[TBL] [Abstract][Full Text] [Related]
8. Effects of endocytosis inhibitors on internalization of human IgG by Caco-2 human intestinal epithelial cells.
Sato K; Nagai J; Mitsui N; Ryoko Yumoto ; Takano M
Life Sci; 2009 Dec; 85(23-26):800-7. PubMed ID: 19879882
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.
Lendvai G; Velikyan I; Bergström M; Estrada S; Laryea D; Välilä M; Salomäki S; Långström B; Roivainen A
Eur J Pharm Sci; 2005 Sep; 26(1):26-38. PubMed ID: 15941654
[TBL] [Abstract][Full Text] [Related]
10. Interactions between single-stranded DNA binding protein and oligonucleotide analogs with different backbone chemistries.
Cheng X; DeLong RK; Wickstrom E; Kligshteyn M; Demirdji SH; Caruthers MH; Juliano RL
J Mol Recognit; 1997; 10(2):101-7. PubMed ID: 9376128
[TBL] [Abstract][Full Text] [Related]
11. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.
Ghosh MK; Ghosh K; Cohen JS
Anticancer Drug Des; 1993 Feb; 8(1):15-32. PubMed ID: 8386513
[TBL] [Abstract][Full Text] [Related]
12. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells.
Cavet ME; West M; Simmons NL
Br J Pharmacol; 1996 Jul; 118(6):1389-96. PubMed ID: 8832062
[TBL] [Abstract][Full Text] [Related]
13. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM
Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525
[TBL] [Abstract][Full Text] [Related]
14. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
15. Absorption of antisense oligonucleotides in rat intestine: effect of chemistry and length.
Khatsenko O; Morgan R; Truong L; York-Defalco C; Sasmor H; Conklin B; Geary RS
Antisense Nucleic Acid Drug Dev; 2000 Feb; 10(1):35-44. PubMed ID: 10726659
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages.
Shoji Y; Akhtar S; Periasamy A; Herman B; Juliano RL
Nucleic Acids Res; 1991 Oct; 19(20):5543-50. PubMed ID: 1658734
[TBL] [Abstract][Full Text] [Related]
17. Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2.
Tamura K; Lee CP; Smith PL; Borchardt RT
Pharm Res; 1996 Nov; 13(11):1663-7. PubMed ID: 8956331
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay.
Gaus HJ; Gupta R; Chappell AE; Østergaard ME; Swayze EE; Seth PP
Nucleic Acids Res; 2019 Feb; 47(3):1110-1122. PubMed ID: 30566688
[TBL] [Abstract][Full Text] [Related]
19. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.
Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST
Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.
Zhao Q; Matson S; Herrera CJ; Fisher E; Yu H; Krieg AM
Antisense Res Dev; 1993; 3(1):53-66. PubMed ID: 8495106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
